Your Search Results

Molecular investigations of receptors involved in neurological disorders

The Laboratory of Molecular Neuroscience investigates molecular regulation and drug interactions that occur in receptors associated with neurological diseases. more...

Supervisor(s): Holsinger, Damian (Dr)

Advanced Instrumentation and Computational Methods for in vivo Molecular Imaging

There are opportunities for physics and engineering graduates to undertake research leading to a PhD with the medical imaging physics group at the University of Sydney node of the N more...

Supervisor(s): Meikle, Steven (Professor)

From the molecular study of receptor-ligand interactions to novel biomarkers of disease and non-invasive brain imaging - opportunities in basic and clinically oriented research

Methodologically broad but thematically focused on the role of receptors in glial (non-neuronal) cells in brain disease, the available basic science projects are concerned with the more...

Supervisor(s): Banati, Richard (Professor)

Metal Ion Sensors for Medicinal and Environmental Applications

Metal cations like Zn(II), Cu and K(I) play a raft of important signalling roles in our bodies; others such as Hg(II), Cd(II) and Pb(II) are toxic pollutants in the environment. more...

Supervisor(s): Rutledge, Peter (Associate Professor), Canning, John (Honorary Professor)

Pharmacological targeting of sphingosine 1-phosphate receptors to promote remyelination in Alzheimer’s disease and multiple sclerosis

In this project you will investigate a new molecular pathway that is required for normal myelin formation, and the therapeutic potential of targeting this pathway to promote remyeli more...

Supervisor(s): Don, Anthony (Associate Professor)

Fluorescent sensors for oxidative stress

Oxidative stress is associated with all diseases of ageing, and there is therefore a need for better tools to identify and quantify the condition. We are developing novel fluorescen more...

Supervisor(s): New, Elizabeth (Associate Professor)

Discovery and validation of new ceramide synthase inhibitors to treat metabolic disease

Ceramide synthase enzyme isoforms 1, 5, and 6, are heavily implicated as drivers of obesity, insulin resistance, and diabetes. Targeting these enzymes is expected to yield new thera more...

Supervisor(s): Don, Anthony (Associate Professor), Qi, Jacob (Dr)